Vital Pharmaceuticals, Inc., commonly known for its flagship brand Bang Energy, is a leading player in the beverage industry, headquartered in the United States. Founded in 1993, the company has established itself as a pioneer in the performance energy drink sector, focusing on innovative formulations that cater to fitness enthusiasts and health-conscious consumers. With a strong presence across North America and expanding operations internationally, Vital Pharmaceuticals is renowned for its unique blend of energy-boosting ingredients and essential amino acids. The brand's commitment to quality and performance has garnered a loyal customer base, positioning it as a formidable competitor in the energy drink market. Notable achievements include rapid growth in market share and recognition for its cutting-edge product offerings, which continue to set trends within the industry.
How does Vital Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vital Pharmaceuticals, Inc.'s score of 18 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vital Pharmaceuticals, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year. As a result, there are no specific figures regarding their total emissions or breakdowns by Scope 1, Scope 2, or Scope 3. Furthermore, the company has not outlined any formal reduction targets or commitments related to climate action. There are no initiatives reported under the Science Based Targets initiative (SBTi) or other climate pledges, indicating a lack of publicly stated goals for emissions reduction. In the absence of specific emissions data and reduction commitments, it is essential to note that the company may still be evaluating its climate strategy in line with industry standards. As the focus on sustainability and carbon neutrality continues to grow, Vital Pharmaceuticals, Inc. may consider establishing measurable targets in the future to align with broader environmental goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vital Pharmaceuticals, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.